ArticleFunctional & integrative genomics2026
Bioinformatic identification of THY1 as a target in osteoarthritis and its effects on chondrocyte senescence and apoptosis.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Osteoarthritis (OA) is the most prevalent degenerative joint disease worldwide and imposes a substantial public health burden due to the lack of effective disease-modifying drugs. Exosome-related genes participate in exosome biogenesis, cargo sorting, and secretion, serving as critical regulatory elements in exosome-mediated intercellular communication. However, their systematic characterization in OA and their potential as diagnostic or therapeutic targets remain largely unexplored. We obtained OA and normal control samples from the GEO database. Using exosome-related gene signatures as a filtering strategy, we integrated differential expression analysis, protein-protein interaction network assessment, and machine learning algorithms to screen for key diagnostic genes, and constructed and externally validated diagnostic models and nomograms. Enrichment analysis and immune infiltration assessment were performed to explore biological functions and immune microenvironment features. Cellular experiments were conducted to validate the effects of the prioritized gene THY1 on chondrocyte apoptosis, senescence, mitochondrial function, and cell viability. We successfully identified THY1, FAP, and TIMP4 as independent diagnostic markers for OA and constructed a diagnostic model and nomogram with high applicability, whose reliability was validated in an external validation cohort. Enrichment and immune infiltration analyses preliminarily identified two OA subtypes with distinct immune infiltration profiles. Cellular experiments confirmed that THY1 overexpression promoted chondrocyte senescence and apoptosis under OA-like inflammatory conditions, while impairing mitochondrial function and cell viability. Through bioinformatic screening and in vitro experimental validation, this study reveals the pro-apoptotic and pro-senescent regulatory effects of THY1 on chondrocytes under inflammatory conditions, and establishes a diagnostic model and subtyping framework for OA based on three genes, offering new perspectives for stratified diagnosis and future translational research in OA.
Indexed as
Identifiers
42640506What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.